Viking Therapeutics, Inc.
VKTXFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Viking Therapeutics, Inc. Makes Money
No flow chart is shown because the available revenue and expense lines do not reconcile exactly. The reported financial history below remains available.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 12 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 3, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| ADIRONDACK TRUST CO | 2026-03-31 | 188 | $6.12K | SEC filing |
| Atlantic Union Bankshares Corp | 2026-03-31 | 100 | $3.25K | SEC filing |
| PNC FINANCIAL SERVICES GROUP, INC. | 2026-03-31 | 7,956 | $259K | SEC filing |
| Private Wealth Management Group, LLC | 2026-03-31 | 112 | $3.65K | SEC filing |
| Nemes Rush Group LLC | 2026-03-31 | 5,168 | $168K | SEC filing |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 2026-03-31 | 183,846 | $5.5M | SEC filing |
| Inspire Advisors, LLC | 2026-03-31 | 9,433 | $307K | SEC filing |
| PlanVest Financial, Inc | 2026-03-31 | 12 | $390 | SEC filing |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 2026-03-31 | 5,927 | $195K | SEC filing |
| MH & ASSOCIATES SECURITIES MANAGEMENT CORP /ADV | 2026-03-31 | 65,422 | $2.13M | SEC filing |
| Handelsbanken Fonder AB | 2026-03-31 | 35,700 | Not shown | SEC filing |
| TWO SIGMA INVESTMENTS, LP | 2026-03-31 | 4,432,142 | $144M | SEC filing |
| CAPSTONE INVESTMENT ADVISORS, LLC | 2026-03-31 | 12,060 | $392K | SEC filing |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 2026-03-31 | 8,937 | $267K | SEC filing |
| MV CAPITAL MANAGEMENT, INC. | 2026-03-31 | 55 | $1.79K | SEC filing |
| STRS OHIO | 2026-03-31 | 2,606 | $84.8K | SEC filing |
| Morton Brown Family Wealth, LLC | 2026-03-31 | 450 | $14.6K | SEC filing |
| NISA INVESTMENT ADVISORS, LLC | 2026-03-31 | 18,847 | $613K | SEC filing |
| Ares Financial Consulting, LLC | 2026-03-31 | 42 | $1.38K | SEC filing |
| Banque Cantonale Vaudoise | 2026-03-31 | 3,881 | $126K | SEC filing |
- Each value is checked against Viking Therapeutics, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 1 row: the filed value is about 1,000 times too small for the share count at Viking Therapeutics, Inc.'s share price.
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Viking Therapeutics, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-01-05 · Lian Brian: Larger than 89 of the 90 other insider sales of Common Stock, par value $0.00001 per share on file. SEC filing
- 2025-01-06 · Lian Brian: Larger than all 90 other insider sales of Common Stock, par value $0.00001 per share on file. SEC filing
- 2024-09-20 · Lian Brian: Larger than 85 of the 90 other insider sales of Common Stock, par value $0.00001 per share on file. SEC filing
- 2024-09-20 · Lian Brian: Larger than 87 of the 90 other insider sales of Common Stock, par value $0.00001 per share on file. SEC filing
- 2024-08-19 · Lian Brian: Larger than 83 of the 90 other insider sales of Common Stock, par value $0.00001 per share on file. SEC filing
- 2024-07-30 · Lian Brian: Larger than 82 of the 90 other insider sales of Common Stock, par value $0.00001 per share on file. SEC filing
- 2024-05-01 · Mancini Marianna: Larger than 86 of the 90 other insider sales of Common Stock, par value $0.00001 per share on file. SEC filing
- 2024-05-01 · Mancini Marianna: Larger than 88 of the 90 other insider sales of Common Stock, par value $0.00001 per share on file. SEC filing
- 2024-02-08 · Lian Brian: Larger than 84 of the 90 other insider sales of Common Stock, par value $0.00001 per share on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-03-10 | Aubuchon Neil William · Chief Commercial Officer | Common Stock, par value $0.00001 per share | P — Open market or private purchase | +4,475 | 33.50 | SEC filing |
| 2026-01-05 | ZANTE GREG · Chief Financial Officer | Common Stock, par value $0.00001 per share | S — Open market or private sale | −13,900 | 33.38 | SEC filing |
| 2026-01-05 | Lian Brian · President & CEO | Common Stock, par value $0.00001 per share | S — Open market or private sale | −41,276 | 34.22 | SEC filing |
| 2026-01-05 | Mancini Marianna · Chief Operating Officer | Common Stock, par value $0.00001 per share | S — Open market or private sale | −13,600 | 33.37 | SEC filing |
| 2026-01-05 | ZANTE GREG · Chief Financial Officer | Common Stock, par value $0.00001 per share | S — Open market or private sale | −31,961 | 32.30 | SEC filing |
| 2026-01-05 | ZANTE GREG · Chief Financial Officer | Common Stock, par value $0.00001 per share | S — Open market or private sale | −10,300 | 34.24 | SEC filing |
| 2026-01-05 | Lian Brian · President & CEO | Common Stock, par value $0.00001 per share | S — Open market or private sale | −6,400 | 35.07 | SEC filing |
| 2026-01-05 | Mancini Marianna · Chief Operating Officer | Common Stock, par value $0.00001 per share | S — Open market or private sale | −31,961 | 32.29 | SEC filing |
Showing 8 of 12 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-01 | Chen Hubert C · Chief Medical Officer | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +190,000 | SEC filing |
| 2026-01-12 | Aubuchon Neil William · Chief Commercial Officer | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +180,000 | SEC filing |
| 2026-01-02 | FOEHR MATTHEW W · Director | Stock Option (Right to Buy) | M — Exercise or conversion of derivative security | −16,000 | SEC filing |
| 2026-01-02 | FOEHR MATTHEW W · Director | Common Stock, par value $0.00001 per share | M — Exercise or conversion of derivative security | +16,000 | SEC filing |
| 2026-01-02 | MACARTNEY LAWSON · Director | Common Stock, par value $0.00001 per share | A — Grant, award, or other acquisition | +3,150 | SEC filing |
| 2026-01-02 | Mancini Marianna · Chief Operating Officer | Common Stock, par value $0.00001 per share | A — Grant, award, or other acquisition | +41,000 | SEC filing |
| 2026-01-02 | SINGLETON J MATTHEW · Director | Common Stock, par value $0.00001 per share | A — Grant, award, or other acquisition | +3,150 | SEC filing |
| 2026-01-02 | SINGLETON J MATTHEW · Director | Stock Option (Right to Buy) | A — Grant, award, or other acquisition | +20,400 | SEC filing |
Showing 8 of 30 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.